Medical Care
Global Pediatric Influenza Treatment Market Research Report 2025
- Sep 18, 25
- ID: 508832
- Pages: 78
- Figures: 78
- Views: 19
This report aims to provide a comprehensive presentation of the global market for Pediatric Influenza Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Influenza Treatment.
The Pediatric Influenza Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Influenza Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Influenza Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.
Segment by Type
Antiviral Drug
Antipyretic
Neuraminidase inhibitor
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Influenza Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Pediatric Influenza Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Influenza Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Influenza Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.
Segment by Type
Antiviral Drug
Antipyretic
Neuraminidase inhibitor
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Influenza Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Influenza Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antiviral Drug
1.2.3 Antipyretic
1.2.4 Neuraminidase inhibitor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pediatric Influenza Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Influenza Treatment Market Perspective (2020-2031)
2.2 Global Pediatric Influenza Treatment Growth Trends by Region
2.2.1 Global Pediatric Influenza Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Influenza Treatment Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Influenza Treatment Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Influenza Treatment Market Dynamics
2.3.1 Pediatric Influenza Treatment Industry Trends
2.3.2 Pediatric Influenza Treatment Market Drivers
2.3.3 Pediatric Influenza Treatment Market Challenges
2.3.4 Pediatric Influenza Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Influenza Treatment Players by Revenue
3.1.1 Global Top Pediatric Influenza Treatment Players by Revenue (2020-2025)
3.1.2 Global Pediatric Influenza Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Influenza Treatment Revenue
3.4 Global Pediatric Influenza Treatment Market Concentration Ratio
3.4.1 Global Pediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Influenza Treatment Revenue in 2024
3.5 Global Key Players of Pediatric Influenza Treatment Head office and Area Served
3.6 Global Key Players of Pediatric Influenza Treatment, Product and Application
3.7 Global Key Players of Pediatric Influenza Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Influenza Treatment Breakdown Data by Type
4.1 Global Pediatric Influenza Treatment Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Influenza Treatment Forecasted Market Size by Type (2026-2031)
5 Pediatric Influenza Treatment Breakdown Data by Application
5.1 Global Pediatric Influenza Treatment Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Influenza Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Influenza Treatment Market Size (2020-2031)
6.2 North America Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Influenza Treatment Market Size by Country (2020-2025)
6.4 North America Pediatric Influenza Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Influenza Treatment Market Size (2020-2031)
7.2 Europe Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Influenza Treatment Market Size by Country (2020-2025)
7.4 Europe Pediatric Influenza Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Influenza Treatment Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Influenza Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Influenza Treatment Market Size (2020-2031)
9.2 Latin America Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Influenza Treatment Market Size by Country (2020-2025)
9.4 Latin America Pediatric Influenza Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Influenza Treatment Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 GlaxoSmithKline Plc.
11.2.1 GlaxoSmithKline Plc. Company Details
11.2.2 GlaxoSmithKline Plc. Business Overview
11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Introduction
11.2.4 GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.2.5 GlaxoSmithKline Plc. Recent Development
11.3 NATCO Pharma Limited.
11.3.1 NATCO Pharma Limited. Company Details
11.3.2 NATCO Pharma Limited. Business Overview
11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Introduction
11.3.4 NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.3.5 NATCO Pharma Limited. Recent Development
11.4 NESHER PHARMS
11.4.1 NESHER PHARMS Company Details
11.4.2 NESHER PHARMS Business Overview
11.4.3 NESHER PHARMS Pediatric Influenza Treatment Introduction
11.4.4 NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.4.5 NESHER PHARMS Recent Development
11.5 Johnson & Johnsons Inc.
11.5.1 Johnson & Johnsons Inc. Company Details
11.5.2 Johnson & Johnsons Inc. Business Overview
11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Introduction
11.5.4 Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.5.5 Johnson & Johnsons Inc. Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Pediatric Influenza Treatment Introduction
11.6.4 Cipla Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.6.5 Cipla Recent Development
11.7 Hetero Pharma
11.7.1 Hetero Pharma Company Details
11.7.2 Hetero Pharma Business Overview
11.7.3 Hetero Pharma Pediatric Influenza Treatment Introduction
11.7.4 Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.7.5 Hetero Pharma Recent Development
11.8 Teva Pharmaceutical pvt. Ltd.
11.8.1 Teva Pharmaceutical pvt. Ltd. Company Details
11.8.2 Teva Pharmaceutical pvt. Ltd. Business Overview
11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Introduction
11.8.4 Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.8.5 Teva Pharmaceutical pvt. Ltd. Recent Development
11.9 Olainfarm JSC
11.9.1 Olainfarm JSC Company Details
11.9.2 Olainfarm JSC Business Overview
11.9.3 Olainfarm JSC Pediatric Influenza Treatment Introduction
11.9.4 Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.9.5 Olainfarm JSC Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.10.5 Gilead Sciences, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Influenza Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antiviral Drug
1.2.3 Antipyretic
1.2.4 Neuraminidase inhibitor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pediatric Influenza Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Influenza Treatment Market Perspective (2020-2031)
2.2 Global Pediatric Influenza Treatment Growth Trends by Region
2.2.1 Global Pediatric Influenza Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Influenza Treatment Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Influenza Treatment Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Influenza Treatment Market Dynamics
2.3.1 Pediatric Influenza Treatment Industry Trends
2.3.2 Pediatric Influenza Treatment Market Drivers
2.3.3 Pediatric Influenza Treatment Market Challenges
2.3.4 Pediatric Influenza Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Influenza Treatment Players by Revenue
3.1.1 Global Top Pediatric Influenza Treatment Players by Revenue (2020-2025)
3.1.2 Global Pediatric Influenza Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Influenza Treatment Revenue
3.4 Global Pediatric Influenza Treatment Market Concentration Ratio
3.4.1 Global Pediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Influenza Treatment Revenue in 2024
3.5 Global Key Players of Pediatric Influenza Treatment Head office and Area Served
3.6 Global Key Players of Pediatric Influenza Treatment, Product and Application
3.7 Global Key Players of Pediatric Influenza Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Influenza Treatment Breakdown Data by Type
4.1 Global Pediatric Influenza Treatment Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Influenza Treatment Forecasted Market Size by Type (2026-2031)
5 Pediatric Influenza Treatment Breakdown Data by Application
5.1 Global Pediatric Influenza Treatment Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Influenza Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Influenza Treatment Market Size (2020-2031)
6.2 North America Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Influenza Treatment Market Size by Country (2020-2025)
6.4 North America Pediatric Influenza Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Influenza Treatment Market Size (2020-2031)
7.2 Europe Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Influenza Treatment Market Size by Country (2020-2025)
7.4 Europe Pediatric Influenza Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Influenza Treatment Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Influenza Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Influenza Treatment Market Size (2020-2031)
9.2 Latin America Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Influenza Treatment Market Size by Country (2020-2025)
9.4 Latin America Pediatric Influenza Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Influenza Treatment Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 GlaxoSmithKline Plc.
11.2.1 GlaxoSmithKline Plc. Company Details
11.2.2 GlaxoSmithKline Plc. Business Overview
11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Introduction
11.2.4 GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.2.5 GlaxoSmithKline Plc. Recent Development
11.3 NATCO Pharma Limited.
11.3.1 NATCO Pharma Limited. Company Details
11.3.2 NATCO Pharma Limited. Business Overview
11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Introduction
11.3.4 NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.3.5 NATCO Pharma Limited. Recent Development
11.4 NESHER PHARMS
11.4.1 NESHER PHARMS Company Details
11.4.2 NESHER PHARMS Business Overview
11.4.3 NESHER PHARMS Pediatric Influenza Treatment Introduction
11.4.4 NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.4.5 NESHER PHARMS Recent Development
11.5 Johnson & Johnsons Inc.
11.5.1 Johnson & Johnsons Inc. Company Details
11.5.2 Johnson & Johnsons Inc. Business Overview
11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Introduction
11.5.4 Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.5.5 Johnson & Johnsons Inc. Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Pediatric Influenza Treatment Introduction
11.6.4 Cipla Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.6.5 Cipla Recent Development
11.7 Hetero Pharma
11.7.1 Hetero Pharma Company Details
11.7.2 Hetero Pharma Business Overview
11.7.3 Hetero Pharma Pediatric Influenza Treatment Introduction
11.7.4 Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.7.5 Hetero Pharma Recent Development
11.8 Teva Pharmaceutical pvt. Ltd.
11.8.1 Teva Pharmaceutical pvt. Ltd. Company Details
11.8.2 Teva Pharmaceutical pvt. Ltd. Business Overview
11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Introduction
11.8.4 Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.8.5 Teva Pharmaceutical pvt. Ltd. Recent Development
11.9 Olainfarm JSC
11.9.1 Olainfarm JSC Company Details
11.9.2 Olainfarm JSC Business Overview
11.9.3 Olainfarm JSC Pediatric Influenza Treatment Introduction
11.9.4 Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.9.5 Olainfarm JSC Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025)
11.10.5 Gilead Sciences, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antiviral Drug
Table 3. Key Players of Antipyretic
Table 4. Key Players of Neuraminidase inhibitor
Table 5. Key Players of Others
Table 6. Global Pediatric Influenza Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pediatric Influenza Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pediatric Influenza Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pediatric Influenza Treatment Market Share by Region (2020-2025)
Table 10. Global Pediatric Influenza Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pediatric Influenza Treatment Market Share by Region (2026-2031)
Table 12. Pediatric Influenza Treatment Market Trends
Table 13. Pediatric Influenza Treatment Market Drivers
Table 14. Pediatric Influenza Treatment Market Challenges
Table 15. Pediatric Influenza Treatment Market Restraints
Table 16. Global Pediatric Influenza Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pediatric Influenza Treatment Market Share by Players (2020-2025)
Table 18. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2024)
Table 19. Ranking of Global Top Pediatric Influenza Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pediatric Influenza Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pediatric Influenza Treatment, Headquarters and Area Served
Table 22. Global Key Players of Pediatric Influenza Treatment, Product and Application
Table 23. Global Key Players of Pediatric Influenza Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Influenza Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pediatric Influenza Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Pediatric Influenza Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pediatric Influenza Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Pediatric Influenza Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pediatric Influenza Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Pediatric Influenza Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pediatric Influenza Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pediatric Influenza Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. F. Hoffmann-La Roche Ltd Company Details
Table 49. F. Hoffmann-La Roche Ltd Business Overview
Table 50. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product
Table 51. F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 52. F. Hoffmann-La Roche Ltd Recent Development
Table 53. GlaxoSmithKline Plc. Company Details
Table 54. GlaxoSmithKline Plc. Business Overview
Table 55. GlaxoSmithKline Plc. Pediatric Influenza Treatment Product
Table 56. GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 57. GlaxoSmithKline Plc. Recent Development
Table 58. NATCO Pharma Limited. Company Details
Table 59. NATCO Pharma Limited. Business Overview
Table 60. NATCO Pharma Limited. Pediatric Influenza Treatment Product
Table 61. NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 62. NATCO Pharma Limited. Recent Development
Table 63. NESHER PHARMS Company Details
Table 64. NESHER PHARMS Business Overview
Table 65. NESHER PHARMS Pediatric Influenza Treatment Product
Table 66. NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 67. NESHER PHARMS Recent Development
Table 68. Johnson & Johnsons Inc. Company Details
Table 69. Johnson & Johnsons Inc. Business Overview
Table 70. Johnson & Johnsons Inc. Pediatric Influenza Treatment Product
Table 71. Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnsons Inc. Recent Development
Table 73. Cipla Company Details
Table 74. Cipla Business Overview
Table 75. Cipla Pediatric Influenza Treatment Product
Table 76. Cipla Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 77. Cipla Recent Development
Table 78. Hetero Pharma Company Details
Table 79. Hetero Pharma Business Overview
Table 80. Hetero Pharma Pediatric Influenza Treatment Product
Table 81. Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 82. Hetero Pharma Recent Development
Table 83. Teva Pharmaceutical pvt. Ltd. Company Details
Table 84. Teva Pharmaceutical pvt. Ltd. Business Overview
Table 85. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Product
Table 86. Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 87. Teva Pharmaceutical pvt. Ltd. Recent Development
Table 88. Olainfarm JSC Company Details
Table 89. Olainfarm JSC Business Overview
Table 90. Olainfarm JSC Pediatric Influenza Treatment Product
Table 91. Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 92. Olainfarm JSC Recent Development
Table 93. Gilead Sciences, Inc. Company Details
Table 94. Gilead Sciences, Inc. Business Overview
Table 95. Gilead Sciences, Inc. Pediatric Influenza Treatment Product
Table 96. Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 97. Gilead Sciences, Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Pediatric Influenza Treatment Picture
Figure 2. Global Pediatric Influenza Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Influenza Treatment Market Share by Type: 2024 VS 2031
Figure 4. Antiviral Drug Features
Figure 5. Antipyretic Features
Figure 6. Neuraminidase inhibitor Features
Figure 7. Others Features
Figure 8. Global Pediatric Influenza Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pediatric Influenza Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Pediatric Influenza Treatment Report Years Considered
Figure 15. Global Pediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pediatric Influenza Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pediatric Influenza Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Pediatric Influenza Treatment Market Share by Players in 2024
Figure 19. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pediatric Influenza Treatment Revenue in 2024
Figure 21. North America Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 23. United States Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 27. Germany Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pediatric Influenza Treatment Market Share by Region (2020-2031)
Figure 35. China Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 51. GlaxoSmithKline Plc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 52. NATCO Pharma Limited. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 53. NESHER PHARMS Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 54. Johnson & Johnsons Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 55. Cipla Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 56. Hetero Pharma Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 57. Teva Pharmaceutical pvt. Ltd. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 58. Olainfarm JSC Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 59. Gilead Sciences, Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Pediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antiviral Drug
Table 3. Key Players of Antipyretic
Table 4. Key Players of Neuraminidase inhibitor
Table 5. Key Players of Others
Table 6. Global Pediatric Influenza Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pediatric Influenza Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pediatric Influenza Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pediatric Influenza Treatment Market Share by Region (2020-2025)
Table 10. Global Pediatric Influenza Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pediatric Influenza Treatment Market Share by Region (2026-2031)
Table 12. Pediatric Influenza Treatment Market Trends
Table 13. Pediatric Influenza Treatment Market Drivers
Table 14. Pediatric Influenza Treatment Market Challenges
Table 15. Pediatric Influenza Treatment Market Restraints
Table 16. Global Pediatric Influenza Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pediatric Influenza Treatment Market Share by Players (2020-2025)
Table 18. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2024)
Table 19. Ranking of Global Top Pediatric Influenza Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pediatric Influenza Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pediatric Influenza Treatment, Headquarters and Area Served
Table 22. Global Key Players of Pediatric Influenza Treatment, Product and Application
Table 23. Global Key Players of Pediatric Influenza Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Influenza Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pediatric Influenza Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Pediatric Influenza Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pediatric Influenza Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Pediatric Influenza Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pediatric Influenza Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Pediatric Influenza Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pediatric Influenza Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pediatric Influenza Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. F. Hoffmann-La Roche Ltd Company Details
Table 49. F. Hoffmann-La Roche Ltd Business Overview
Table 50. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product
Table 51. F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 52. F. Hoffmann-La Roche Ltd Recent Development
Table 53. GlaxoSmithKline Plc. Company Details
Table 54. GlaxoSmithKline Plc. Business Overview
Table 55. GlaxoSmithKline Plc. Pediatric Influenza Treatment Product
Table 56. GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 57. GlaxoSmithKline Plc. Recent Development
Table 58. NATCO Pharma Limited. Company Details
Table 59. NATCO Pharma Limited. Business Overview
Table 60. NATCO Pharma Limited. Pediatric Influenza Treatment Product
Table 61. NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 62. NATCO Pharma Limited. Recent Development
Table 63. NESHER PHARMS Company Details
Table 64. NESHER PHARMS Business Overview
Table 65. NESHER PHARMS Pediatric Influenza Treatment Product
Table 66. NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 67. NESHER PHARMS Recent Development
Table 68. Johnson & Johnsons Inc. Company Details
Table 69. Johnson & Johnsons Inc. Business Overview
Table 70. Johnson & Johnsons Inc. Pediatric Influenza Treatment Product
Table 71. Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnsons Inc. Recent Development
Table 73. Cipla Company Details
Table 74. Cipla Business Overview
Table 75. Cipla Pediatric Influenza Treatment Product
Table 76. Cipla Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 77. Cipla Recent Development
Table 78. Hetero Pharma Company Details
Table 79. Hetero Pharma Business Overview
Table 80. Hetero Pharma Pediatric Influenza Treatment Product
Table 81. Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 82. Hetero Pharma Recent Development
Table 83. Teva Pharmaceutical pvt. Ltd. Company Details
Table 84. Teva Pharmaceutical pvt. Ltd. Business Overview
Table 85. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Product
Table 86. Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 87. Teva Pharmaceutical pvt. Ltd. Recent Development
Table 88. Olainfarm JSC Company Details
Table 89. Olainfarm JSC Business Overview
Table 90. Olainfarm JSC Pediatric Influenza Treatment Product
Table 91. Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 92. Olainfarm JSC Recent Development
Table 93. Gilead Sciences, Inc. Company Details
Table 94. Gilead Sciences, Inc. Business Overview
Table 95. Gilead Sciences, Inc. Pediatric Influenza Treatment Product
Table 96. Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2020-2025) & (US$ Million)
Table 97. Gilead Sciences, Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Pediatric Influenza Treatment Picture
Figure 2. Global Pediatric Influenza Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Influenza Treatment Market Share by Type: 2024 VS 2031
Figure 4. Antiviral Drug Features
Figure 5. Antipyretic Features
Figure 6. Neuraminidase inhibitor Features
Figure 7. Others Features
Figure 8. Global Pediatric Influenza Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pediatric Influenza Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Pediatric Influenza Treatment Report Years Considered
Figure 15. Global Pediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pediatric Influenza Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pediatric Influenza Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Pediatric Influenza Treatment Market Share by Players in 2024
Figure 19. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pediatric Influenza Treatment Revenue in 2024
Figure 21. North America Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 23. United States Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 27. Germany Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pediatric Influenza Treatment Market Share by Region (2020-2031)
Figure 35. China Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pediatric Influenza Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pediatric Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 51. GlaxoSmithKline Plc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 52. NATCO Pharma Limited. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 53. NESHER PHARMS Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 54. Johnson & Johnsons Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 55. Cipla Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 56. Hetero Pharma Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 57. Teva Pharmaceutical pvt. Ltd. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 58. Olainfarm JSC Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 59. Gilead Sciences, Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232